Hsbc Holdings PLC Fibrogen Inc Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Fibrogen Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 52,211 shares of FGEN stock, worth $19,318. This represents 0.0% of its overall portfolio holdings.

Number of Shares

52,211

Previous 62,639 16.65%

Holding current value

$19,318

Previous $55,000 63.64%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.33 - $1.26 $3,441 - $13,139	-10,428 Reduced 16.65%	52,211 $20,000
Q2 2024 Aug 12, 2024	SELL	$0.89 - $2.36 $17,862 - $47,365	-20,070 Reduced 24.27%	62,639 $55,000
Q1 2024 May 15, 2024	BUY	$0.73 - $2.73 $896 - $3,352	1,228 Added 1.51%	82,709 $194,000
Q4 2023 Feb 12, 2024	BUY	$0.38 - $0.91 $10,339 - $24,759	27,208 Added 50.13%	81,481 $72,000
Q3 2023 Nov 13, 2023	SELL	$0.79 - $2.83 $18,930 - $67,815	-23,963 Reduced 30.63%	54,273 $46,000
Q2 2023 Aug 11, 2023	BUY	$2.49 - $20.59 $194,807 - $1.61 Million	78,236 New	78,236 $211,000
Q3 2022 Nov 14, 2022	BUY	$11.4 - $14.6 $13,395 - $17,155	1,175 Added 9.3%	13,810 $182,000
Q2 2022 Aug 11, 2022	BUY	$7.94 - $12.96 $7,987 - $13,037	1,006 Added 8.65%	12,635 $134,000
Q1 2022 May 16, 2022	BUY	$12.02 - $16.79 $139,780 - $195,250	11,629 New	11,629 $142,000
Q3 2021 Nov 12, 2021	SELL	$10.18 - $26.64 $145,146 - $379,833	-14,258 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$18.57 - $35.68 $93,574 - $179,791	5,039 Added 54.66%	14,258 $379,000
Q1 2021 May 14, 2021	SELL	$31.0 - $55.72 $247,659 - $445,147	-7,989 Reduced 46.43%	9,219 $319,000
Q4 2020 Feb 12, 2021	BUY	$37.09 - $48.97 $276,543 - $365,120	7,456 Added 76.46%	17,208 $638,000
Q3 2020 Nov 12, 2020	SELL	$40.47 - $45.5 $157,306 - $176,858	-3,887 Reduced 28.5%	9,752 $401,000
Q2 2020 Aug 14, 2020	BUY	$32.57 - $42.83 $444,222 - $584,158	13,639 New	13,639 $553,000
Q1 2020 May 15, 2020	SELL	$23.3 - $45.96 $362,687 - $715,413	-15,566 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$34.58 - $48.06 $98,622 - $137,067	2,852 Added 22.43%	15,566 $673,000
Q3 2019 Nov 14, 2019	BUY	$36.98 - $48.45 $90,046 - $117,975	2,435 Added 23.69%	12,714 $470,000
Q2 2019 Aug 13, 2019	SELL	$35.13 - $55.53 $24,555 - $38,815	-699 Reduced 6.37%	10,279 $464,000
Q1 2019 May 15, 2019	BUY	$42.83 - $59.91 $146,564 - $205,012	3,422 Added 45.29%	10,978 $597,000
Q4 2018 Feb 13, 2019	BUY	$37.97 - $60.16 $102,822 - $162,913	2,708 Added 55.86%	7,556 $350,000
Q3 2018 Nov 13, 2018	BUY	$56.3 - $67.25 $1,801 - $2,152	32 Added 0.66%	4,848 $294,000
Q2 2018 Aug 10, 2018	BUY	$44.9 - $64.95 $58,100 - $84,045	1,294 Added 36.74%	4,816 $301,000
Q1 2018 May 11, 2018	SELL	$45.35 - $61.65 $23,400 - $31,811	-516 Reduced 12.78%	3,522 $164,000
Q4 2017 Feb 14, 2018	BUY	$41.95 - $60.1 $23,408 - $33,535	558 Added 16.03%	4,038 $191,000
Q3 2017 Nov 14, 2017	BUY	$33.4 - $53.9 $116,232 - $187,572	3,480	3,480 $187,000

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.9M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $34.7M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Fibrogen Inc Transaction History